NIH-funded research NIH-funded research

A collaborative network for studying rare neurologic disorders.

Official title: University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.

Funded at University of Colorado Denver · NIH-10888384 · Data updated 2026-11-12

This study is working to set up a network of research centers across the country that will focus on helping people with rare brain and genetic disorders, so patients can have better access to new treatments and clinical trials.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startJuly 15, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$416,086
NIH project number5U24NS133991-02
Project IDNIH-10888384 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include individuals diagnosed with rare or ultra-rare neurologic and neurogenetic disorders, both adults and children.

Less likely to help

Patients with common neurologic disorders or those outside the age range of 21 years and older may not receive benefit from this research.

What this research studies

This research aims to create a nationwide network of clinical research centers focused on rare and ultra-rare neurologic and neurogenetic disorders. By integrating expertise from various fields such as neurology, neurosurgery, and neurogenetics, the project seeks to enhance clinical research capabilities and improve patient outcomes. The consortium will leverage established resources and infrastructure to facilitate multi-center clinical trials and support the development of future researchers in the field. Patients may benefit from improved access to innovative treatments and clinical trials through this collaborative effort.

Why it matters

Potential benefit: If successful, this research could lead to better treatment options and improved outcomes for patients with rare neurologic disorders.

How similar studies have gone: Previous collaborative networks have shown success in advancing research and treatment options for rare diseases, indicating a promising approach for this initiative.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Bennett, Jeffrey L — University of Colorado Denver
  • Study coordinator: Bennett, Jeffrey L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.